Integrating albuminuria and GFR in the assessment of diabetic nephropathy (Q37531889)

20 August 2017

1 reference

title

Integrating albuminuria and GFR in the assessment of diabetic nephropathy (English)

1 reference

20 August 2017

George Jerums

1

1 reference

20 August 2017

Sianna Panagiotopoulos

series ordinal

2

1 reference

20 August 2017

Erosha Premaratne

series ordinal

3

1 reference

20 August 2017

Richard J MacIsaac

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Nature Reviews Nephrology

20 August 2017

1 reference

20 August 2017

5

1 reference

20 August 2017

7

1 reference

20 August 2017

397-406

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.91

20 August 2017

0 references

cites work

Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Longitudinal studies on the rate of decline in renal function with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Microalbuminuria: An Early Marker of Renal Involvement in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Predicting diabetic nephropathy in insulin-dependent patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Incipient nephropathy in type 1 (insulin-dependent) diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

First morning voids are more reliable than spot urine samples to assess microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Spectrum of Proteinuria in Type I and Type II Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Progression of proteinuria in type 1 and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Does microalbuminuria predict diabetic nephropathy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Enhancing the predictive value of urinary albumin for diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Regression of microalbuminuria in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Prevention of diabetic renal disease with special reference to microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

'Hypertension' and 'microalbuminuria': the bell tolls for thee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Time to abandon microalbuminuria?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Patterns of renal injury in NIDDM patients with microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Standards of medical care in diabetes--2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Albumin to creatinine ratio: a screening test with limitations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Staging of chronic kidney disease: time for a course correction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

A simple approach to screening for microalbuminuria in a type 1 (insulin-dependent) diabetic population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Prediction of albumin excretion rate from albumin-to-creatinine ratio

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

New and old markers of progression of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Surrogate end points for clinical trials of kidney disease progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Glomerular Filtration Rate, Cardiorenal End Points, and All-Cause Mortality in Type 2 Diabetic Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Progressive decline in renal function in diabetic patients with and without albuminuria.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Nonalbuminuric renal insufficiency in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.91

Albuminuric and non-albuminuric pathways to renal impairment in diabetes

31 March 2020

1 reference

12 December 2020

Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Hyperfiltration in patients with type I diabetes mellitus: a prevalence study.

1 reference

12 December 2020

The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.91

1 reference

20 August 2017

1 reference